These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3680482)

  • 41. [Effect of the intravenous administration of homologous albumin on the lipolytic enzyme activity of rabbit blood plasma].
    Soliternova IB; Nikul'cheva NG; Sanches Serrano D
    Vopr Med Khim; 1984; 30(2):87-91. PubMed ID: 6740999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays.
    Nelson JC; Weiss RM; Wilcox RB
    J Clin Endocrinol Metab; 1994 Jul; 79(1):76-9. PubMed ID: 8027258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concentrations of hormones, glucose, triglycerides and free fatty acids in the plasma of broiler chickens selected for weight gain or food conversion.
    Leenstra FR; Decuypere E; Beuving G; Buyse J; Berghman L; Herremans M
    Br Poult Sci; 1991 Jul; 32(3):619-32. PubMed ID: 1893271
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutropenia and plasma free radical reaction products during haemodialysis.
    Maher ER; Wickens DG; Griffin JF; Kyle P; Curtis JR; Dormandy TL
    Nephrol Dial Transplant; 1988; 3(3):277-83. PubMed ID: 3140101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. How harmless is FFA enhancement?
    Tesserommatis C; Tsopanakis C; Symeonoglou G; Loukissa M; Kouvarou E; Varonos DD
    Eur J Drug Metab Pharmacokinet; 1996; 21(3):213-5. PubMed ID: 8980917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do nonesterified fatty acids displace thyroxin from its plasma binding sites in severe nonthyroidal illnesses?
    Nicolson RE; Reilly CP; Pannall PR; Esposito L; Wellby ML
    Clin Chem; 1989 Jun; 35(6):931-4. PubMed ID: 2731365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The development of lipid metabolism. Effect of short-term application of thyroxine on the level of fatty acids and albumin in serum during ontogenesis in rat.
    Sámel M; Pullmann R; Dobias J; Bukovská E; Lazár J
    Bratisl Lek Listy; 1994 Feb; 95(2):57-63. PubMed ID: 7922627
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors affecting plasma free fatty acids rise during hemodialysis.
    Mingardi G; Branca E; Cini M; Codegoni AM; Mecca G; Bizzi A
    Int J Artif Organs; 1988 Mar; 11(2):95-8. PubMed ID: 3372054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Misleading serum free thyroxine results during low molecular weight heparin treatment.
    Stevenson HP; Archbold GP; Johnston P; Young IS; Sheridan B
    Clin Chem; 1998 May; 44(5):1002-7. PubMed ID: 9590373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of heparin on digitoxin protein binding.
    Lohman JJ; Hooymans PM; Koten ML; Verhey MT; Merkus FW
    Clin Pharmacol Ther; 1985 Jan; 37(1):55-60. PubMed ID: 3965237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonfatty acid-modulated variations in drug binding due to heparin.
    Naranjo CA; Khouw V; Sellers EM
    Clin Pharmacol Ther; 1982 Jun; 31(6):746-52. PubMed ID: 7075122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Variable underestimates by serum free thyroxine (T4) immunoassays of free T4 concentrations in simple solutions.
    Nelson JC; Nayak SS; Wilcox RB
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1373-5. PubMed ID: 7962331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of hepatic binding of thyroxine by cholecystographic agents.
    Felicetta JV; Green WL; Nelp WB
    J Clin Invest; 1980 May; 65(5):1032-40. PubMed ID: 7364937
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The artifactual nature of heparin-induced drug protein-binding alterations.
    Brown JE; Kitchell BB; Bjornsson TD; Shand DG
    Clin Pharmacol Ther; 1981 Nov; 30(5):636-43. PubMed ID: 6794969
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Free fraction of valproic acid: in vitro time-dependent increase and correlation with free fatty acid concentration in human plasma and serum.
    Albani F; Riva R; Procaccianti G; Baruzzi A; Perucca E
    Epilepsia; 1983 Feb; 24(1):65-73. PubMed ID: 6401631
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of low doses of heparin on the plasma binding of phenytoin and prazosin in normal man.
    Schulz P; Giacomini KM; Luttrell S; Turner-Tamiyasu K; Blaschke TF
    Eur J Clin Pharmacol; 1983; 25(2):211-4. PubMed ID: 6628503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increase in platelet aggregation following a rise in plasma free fatty acids.
    Burstein Y; Berns L; Heldenberg D; Kahn Y; Werbin BZ; Tamir I
    Am J Hematol; 1978; 4(1):17-22. PubMed ID: 655154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting ceftriaxone plasma protein binding during open heart surgery.
    Jungbluth GL; Pasko MT; Jusko WJ
    J Pharm Sci; 1989 Oct; 78(10):807-11. PubMed ID: 2600784
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of heparin on free thyroxin as measured by equilibrium dialysis and ultrafiltration.
    Wang YS; Hershman JM; Smith V; Pekary AE
    Clin Chem; 1986 Apr; 32(4):700. PubMed ID: 3955825
    [No Abstract]   [Full Text] [Related]  

  • 60. The effect of continuous heparin infusion for one year on serum cholesterol and triglyceride concentrations in the dog.
    Blackshear PJ; Rohde TD; Varco RL; Buchwald H
    Atherosclerosis; 1977 Jan; 26(1):23-7. PubMed ID: 836345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.